Drug
Rifaximin Ssd
Rifaximin Ssd: highest development phase Phase 3, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rifaximin SSD NCT05297448 | Phase 3 | Hepatic Encephalopathy |
Latest
No recent events.
Follow Rifaximin Ssd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.